URL has been copied successfully!
Skip to content
JBizNews
JBizNews
Primary Navigation Menu
Menu
  • Home
  • Breaking News
  • Top News
  • Markets
  • Crypto
  • Health
  • Real Estate
  • Events
  • Subscribe
  • About JBizNews

Health

  • April 13, 2026

    STAT+: Pharmalittle: We’re reading about a pancreatic cancer pill, FDA rejecting a Replimune drug again, and more


  • April 13, 2026

    On positioning nurses as health experts


  • April 13, 2026

    STAT+: Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients


  • April 13, 2026

    STAT+: Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill


  • April 13, 2026

    STAT+: Spyre Therapeutics IBD drug shows promise in early trial


  • April 13, 2026

    From vision to reality: How ambulatory practices actually become automated


  • April 13, 2026

    Fix operations, not contracts: How to make value-based care work


  • April 13, 2026

    From afterthought to advantage: How health plans are rethinking post-acute care


  • April 13, 2026

    STAT+: Hospitals roll out chatbots, looking to reclaim their role in patients’ health conversations


  • April 13, 2026

    Opinion: STAT+: Landmines await Vinay Prasad’s successor at the FDA


  • April 13, 2026

    Opinion: Erectile dysfunction is more than a sexual issue


  • April 11, 2026

    Opinion: Sports betting is creating a twofold public health crisis for some young men


  • April 11, 2026

    Opinion: What STAT readers think about nutrition education in med school


  • April 10, 2026

    Hospital M&A rebounds after 2025 lull


  • April 10, 2026

    GAO report shows gap between scale of illegal vapes and enforcement 


  • April 10, 2026

    CMS unveils first wave of health tech tools as it pushes data sharing initiative


  • April 10, 2026

    STAT+: GSK says goodbye to leucovorin (again)


  • April 10, 2026

    STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more


  • April 10, 2026

    STAT+: A new trick for old science, and biotech VCs’ scrambled playbook


  • April 10, 2026

    Trump administration admits a glaring error in its accusations about New York health care fraud


  • April 10, 2026

    STAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again


  • April 10, 2026

    Women have awaited a revolution in menopause. It hasn’t arrived.


  • April 10, 2026

    How sports betting apps hook users


  • April 10, 2026

    Opinion: What public health can learn from the MAHA movement


  • April 10, 2026

    Opinion: I’m a MAHA activist. I went into the public health lion’s den — and it changed how I think


  • April 10, 2026

    Opinion: I’m a MAHA activist. I went into the public health lion’s den — and it changed how I think


  • April 9, 2026

    STAT+: Top health officials highlight efforts to make medical records more portable


  • April 9, 2026

    New rules for CDC vaccine panel aim to address lawsuit, empower Kennedy’s allies


  • April 9, 2026

    A new trick for old science, and biotech VCs’ scrambled playbook


  • April 9, 2026

    Orlando Health agrees to acquire Alabama-based RMC Health System


  • April 9, 2026

    Judge allows states’ lawsuit over HHS restructuring to move forward


  • April 9, 2026

    Hims & Hers says limited data stolen in social engineering attack


  • April 9, 2026

    STAT+: A new health care blueprint from a key Democratic think tank


  • April 9, 2026

    Most health AI users don’t rate chatbots as highly accurate: poll


  • April 9, 2026

    STAT+: 5 years after lupus breakthrough, CAR-T is still surprising autoimmunity researchers


  • April 9, 2026

    STAT+: FDA rejects an industry proposal to deregulate some AI devices


  • April 9, 2026

    One year in: How medtech companies are coping with tariff challenges


  • April 9, 2026

    C-section rate in 2025 highest in a decade 


  • April 9, 2026

    STAT+: Genetics may shape GLP-1 outcomes, slightly


  • April 9, 2026

    STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more


Previous Page
1 … 33 34 35 36 37 … 40
Next Page
2026-03-30

JBIZNEWS LLC © 2026